Research on allergic diseases treatment with MSC-CM

JRCT ID: jRCT1051240236

Registered date:06/01/2025

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: allergic diseases
• Date of first enrollment: 01/09/2023
• Study type: Observational

Outcome(s)

• Primary Outcome: Improvement of subjective symptoms

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

Subject Selection Policy

Individuals who have not experienced satisfactory results in the treatment of diseases with standard therapy.
Individuals who, due to concerns about side effects, do not wish to undergo treatment with drugs commonly used in standard therapy and are deemed suitable for treatment with cultured supernatant by a physician.
The following are the selection criteria for patients:

Inclusion Criteria: Patients meeting the following criteria will be eligible for the study:

Individuals aged 18 years or older.
Individuals who possess normal cognitive capacity.
Individuals who can provide written informed consent based on a thorough explanation provided by the physician, after receiving a consent form related to this treatment.
Individuals for whom the attending physician recognizes the necessity of treatment.

Exclude criteria

Exclusion Criteria: Individuals who meet any of the following conditions will be excluded:

Users of narcotics or stimulants.
Individuals deemed unsuitable by the attending physician.

Related Information

• Primary Sponsor: Takigawa Shingo
• Secondary ID(s): ,